Literature DB >> 9179964

Natural propolis extract NIVCRISOL in the treatment of acute and chronic rhinopharyngitis in children.

I Crişan1, C N Zaharia, F Popovici, V Jucu, O Belu, C Dascălu, A Mutiu, A Petrescu.   

Abstract

In the work there are shown the results of a "case control" study carried out in a children collectivity (preschool children and school-children), regarding the action of an aqueous propolis extract, NIVCRISOL, in acute and chronic inflammatory diseases of the upper airways. The preparation, which had a rich content of flavonoids, was administered to a group of preschool children and school-children treated during the whole cold season 1994-1995. The monitoring of the subgroups investigated was performed by clinical observation of the health state and recording of the incidence of symptoms characteristic to acute or chronic rhinopharyngeal diseases, as well as by a periodical laboratory examination for the detection and characterization of viral, microbial and fungal germs carriage. The analysis of the data obtained pointed out the favourable effects of this local treatment, expressed by lowering of the number of cases with acute or chronic symptoms, and decrease and sometimes suppression of the viral-microbial flora carriage of the upper airways. These positive results, the good tolerance of the preparation, the advantages of the therapy with natural products and more economic criteria entitle us to propose the administration of this preparation as an adjuvant medication in the local treatment of some clinical forms of acute or chronic rhinopharyngeal diseases.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 9179964

Source DB:  PubMed          Journal:  Rom J Virol


  7 in total

1.  Pharmacovigilance--Current and Future Challenges. Abstracts of the International Society of Pharmacovigilance annual conference. Dublin, Ireland, 6-8 October 2004.

Authors: 
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 2.  Clinical Evidence of the Benefits of Phytonutrients in Human Healthcare.

Authors:  Nicolas Monjotin; Marie Josèphe Amiot; Jacques Fleurentin; Jean Michel Morel; Sylvie Raynal
Journal:  Nutrients       Date:  2022-04-20       Impact factor: 6.706

3.  Propolis mouthwash: A new beginning.

Authors:  Vidya Dodwad; Bhavna Jha Kukreja
Journal:  J Indian Soc Periodontol       Date:  2011-04

Review 4.  The antiviral and immunomodulatory activities of propolis: An update and future perspectives for respiratory diseases.

Authors:  Andrea Magnavacca; Enrico Sangiovanni; Giorgio Racagni; Mario Dell'Agli
Journal:  Med Res Rev       Date:  2021-11-02       Impact factor: 12.388

5.  Knowledge, Attitudes, and Usage of Apitherapy for Disease Prevention and Treatment among Undergraduate Pharmacy Students in Lithuania.

Authors:  Sonata Trumbeckaite; Jurgita Dauksiene; Jurga Bernatoniene; Valdimaras Janulis
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-30       Impact factor: 2.629

6.  Important developments in romanian propolis research.

Authors:  Liviu Al Mărghitaş; Daniel S Dezmirean; Otilia Bobiş
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-30       Impact factor: 2.629

7.  Role of a proprietary propolis-based product on the wait-and-see approach in acute otitis media and in preventing evolution to tracheitis, bronchitis, or rhinosinusitis from nonstreptococcal pharyngitis.

Authors:  Francesco Di Pierro; Alberto Zanvit; Maria Colombo
Journal:  Int J Gen Med       Date:  2016-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.